Wei Jiang

机构：China Pharmaceutical University, The University of Texas at Arlington, Yale University · ORCID：0000-0001-6120-5278

发表论文 176 篇 · 总被引 2761 次 · h-index 29

代表论文

• Tuning parameters for polygenic risk score methods using GWAS summary statistics from training data (2024 · Nature Communications · 被引 21)
• Integration of expression QTLs with fine mapping via SuSiE (2024 · PLoS Genetics · 被引 12)
• VAV2 exists in extrachromosomal circular DNA and contributes Enzalutamide resistance of prostate cancer via stabilization of AR/ARv7 (2025 · International Journal of Biological Sciences · 被引 10)
• Deep learning-based acoustic emission source localization in heterogeneous rock media without prior wave velocity information (2024 · Measurement Science and Technology · 被引 9)
• Prophylactic supplement with melatonin prevented the brain injury after cardiac arrest in rats (2023 · Scientific Reports · 被引 5)
• Extrachromosomal circular DNA-related SPOCK1 contributes to development and enzalutamide resistance of prostate cancer by regulating epithelial mesenchymal transition (2024 · Heliyon · 被引 4)